TRAW
USDTraws Pharma Inc. Common Stock
$2.200-0.150 (-6.383%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.350
High
$2.355
Low
$2.135
Volume
0.03M
Company Fundamentals
Market Cap
15.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.18M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.97Current $2.200High $19.44
Related News
PR Newswire
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials
ChemDiv, a global provider of integrated drug discovery solutions, today announced the extension of its Chemistry, Manufacturing and Controls (CMC)...
View more
PR Newswire
Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19.
Expert Systems Inc., a leading life sciences accelerator, announced its continued support for Traws Pharma (NASDAQ: TRAW) as the company initiates...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.